Dots Lifescience Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 16-11-2024
- Paid Up Capital ₹ 4.00 M
as on 16-11-2024
- Company Age 16 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.26 Cr
as on 16-11-2024
- Revenue -29.43%
(FY 2023)
- Profit -2.21%
(FY 2023)
- Ebitda -36.83%
(FY 2023)
- Net Worth 19.61%
(FY 2023)
- Total Assets -12.94%
(FY 2023)
About Dots Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹10.26 Cr.
Laxmikameshwari Gamini and Chandramouli Gamini serve as directors at the Company.
- CIN/LLPIN
U85100MH2008PTC188942
- Company No.
188942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dots Lifescience Private Limited offer?
Dots Lifescience Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Organic and Inorganic Solvents, Alcohol Solvents, API (Active Pharmaceutical Ingredients), Isopropyl Alcohol IPA, Glycerine, Refined Glycerine, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Dots Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxmikameshwari Gamini  | Director | 16-Dec-2008 | Current |
| Chandramouli Gamini | Director | 16-Dec-2008 | Current |
Financial Performance of Dots Lifescience.
Dots Lifescience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29.43% decrease. The company also saw a slight decrease in profitability, with a 2.21% decrease in profit. The company's net worth Soared by an impressive increase of 19.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dots Lifescience?
In 2023, Dots Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Green Park Bio-Sciences Private LimitedActive 5 years 9 monthsLaxmikameshwari Gamini and Chandramouli Gamini are mutual person
- Genetek Biosciences Private LimitedActive 3 years 8 months
Laxmikameshwari Gamini and Chandramouli Gamini are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Feb 2015 | ₹4.46 Cr | Open |
The Federal Bank Ltd Creation Date: 15 Sep 2012 | ₹1.90 Cr | Open |
The Federal Bank Ltd Creation Date: 16 Feb 2010 | ₹3.90 Cr | Open |
How Many Employees Work at Dots Lifescience?
Unlock and access historical data on people associated with Dots Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dots Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dots Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
